4//SEC Filing
McKillop Thomas 4
Accession 0000950142-17-001791
CIK 0001145460other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 5:38 PM ET
Size
7.7 KB
Accession
0000950142-17-001791
Insider Transaction Report
Form 4
ALERE INC.ALR
McKillop Thomas
Director
Transactions
- Disposition to Issuer
Employee Stock Option (Right to Buy)
2017-10-03−53,756→ 0 totalExercise: $33.73→ Common Stock (53,756 underlying) - Disposition to Issuer
Common Stock
2017-10-03−5,530→ 0 total
Footnotes (2)
- [F1]Pursuant to that certain Agreement and Plan of Merger, dated as of January 30, 2016, as amended on April 13, 2017 (the "Merger Agreement"), between Alere Inc. (the "Company") and Abbott Laboratories, at the Effective Time (as defined in the Merger Agreement) (the "Effective Time"), each of these shares of the Company's common stock (the "Common Stock") was converted into the right to receive $51.00 (the "Merger Consideration").
- [F2]Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option
Documents
Issuer
ALERE INC.
CIK 0001145460
Entity typeother
Related Parties
1- filerCIK 0001583015
Filing Metadata
- Form type
- 4
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 5:38 PM ET
- Size
- 7.7 KB